Advertisement

Topics

Critical I Limited Company Profile

10:07 EDT 23rd June 2018 | BioPortfolio

Critical I Limited was formed in June 2002 to bring together the expertise and experience of its three principals - Mike Ward, John Hodgson and Keith Binding.
Our objective is simple: to help our clients build robust and vibrant life science businesses by efficiently and effectively mobilising innovations in the commercial and academic life sciences.

We specialise in the European life sciences scene and bring almost 50 years of insight of the global life sciences scene to our work. We are very serious about what we do, and have fun doing it.

We work with organisations from across the bioscience spectrum. They include biotech start-ups, pharmaceutical and agrochemical multinationals, investors, technology transfer organisations, trade associations, public sector research institutes, and government and regulatory bodies.

Building life science enterprises is complex enough without having to fight through layers of unsupported theory, claims and jargon. Clarity in thought and word therefore lie at the heart of our approach. We are highly approachable, yet frank. We bring honesty in appraisal, insight into the mechanisms of development, and a vast network of personal contacts in both science and business to every assignment.

Location

The Colin Sanders Innovation Centre Mewburn Road
Banbury
OX16 9PA
United Kingdom

Contact

Phone: 44 1295 817635
Fax: 44 1295 817636
Email: enquiries@criticali.net


News Articles [135 Associated News Articles listed on BioPortfolio]

The global critical incident monitoring UAV market is forecasted to grow at a CAGR of 17. ...

NEW YORK, Jan. 31, 2018/PRNewswire/ -- About Critical Incident Monitoring UAV The current report focusses on UAVs used for monitoring of critical incidents Read more...

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Surviving sepsis campaign update focuses on critical first hour

(Wolters Kluwer Health) For patients with sepsis, a serious infection causing widespread inflammation, immediate treatment is essential to improve the chances of survival. An updated 'Hour-1 Bundle' o...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Clinical Trials [1048 Associated Clinical Trials listed on BioPortfolio]

Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness

This study will identify the changes in different muscles of patients receiving Extracorporeal Membrane Oxygenation (ECMO) during critical illness and admission to Intensive Care Unit (ICU...

Evaluation of the Association Between Day and Time of Admission to Critical Care and Acute Hospital Outcome

A retrospective analysis of the Case Mix Programme database to evaluate the association between day and time of admission to critical care and acute hospital outcome for unplanned admissio...

Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data

The aim of the proposed study is to better understand the epidemiology of, risk factors for and consequences of critical illness leading to improvements in the risk models used to underpin...

Cost Effectiveness Analysis of Critical Care in Resource Limited Setting

The purpose of this study was to examine the cost effectiveness of critical care in a middle income country with limited resources. The main study hypothesis was that critical care is cos...

Critical Incidents Related to Anesthesia and Intensive Care: A Study in a Tertiary Hospital

Critical incidents in anesthesia is one of the most valuable methods to assess the safety of anesthesia practice among different types of patients. Most of the studies in this regards are ...

Companies [875 Associated Companies listed on BioPortfolio]

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

SIEMENS CANADA LIMITED

Carter Validus Mission Critical REIT II, Inc.

Carter Validus Mission Critical REIT II, Inc. is a public, non-traded company that intends to qualify as a real estate investment trust (REIT). The REIT intends to acquire ...

More Information about "Critical I Limited" on BioPortfolio

We have published hundreds of Critical I Limited news stories on BioPortfolio along with dozens of Critical I Limited Clinical Trials and PubMed Articles about Critical I Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Critical I Limited Companies in our database. You can also find out about relevant Critical I Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record